Sort
16,300 grants matching “fatty liver disease”
Elucidating the Role and Regulation of Proteostasis in Hepatic Fibrogenesis
$426,530Jessica L Maiers · Indiana University Indianapolis · R01 · FY2023 · DK
Sympathetic circadian dysfunction in obesity-related hepatocarcinogenesis
$426,448Loning None Fu · Baylor College Of Medicine · R01 · FY2022 · CA
Dietary And Lifestyle Determinants Of Colon Cancer Recurrence and Survival
$426,443Charles S Fuchs · Dana-Farber Cancer Inst · R01 · FY2015 · CA
Boston OAIC: A Translational Approach to Function Promoting Therapies
$426,342Shalendar Bhasin · Brigham And Women'S Hospital · P30 · FY2022 · AG
Role of PDZK1 in lipid metabolism and atherosclerosis
$426,300Olivier N. Kocher · Beth Israel Deaconess Medical Center · R01 · FY2014 · HL
NUTRITION AND LIPOPROTEIN METABOLISM IN ATHEROSCLEROSIS
$426,125Wake Forest University Health Sciences · R01 · FY2004 · HL
TET1 in non-alcoholic fatty liver disease development
$426,069Chiung-Kuei Huang · Tulane University Of Louisiana · R01 · FY2024 · DK
Molecular Regulation of Apoprotein B Degradation
$426,053Edward A Fisher · New York University School Of Medicine · R01 · FY2016 · HL
Therapeutic Potential of Estrogen-Regulated Metabolism and Cardiovascular Risk
$426,049John Micheal Stafford · Vanderbilt University Medical Center · R01 · FY2022 · DK
Macronutrients, Mitochondria and Blood Metabolome/Proteome Disease Risk Profiles
$425,963Bruce S Kristal · Brigham And Women'S Hospital · U01 · FY2008 · ES
Serum markers of glucagon sensitivity in calorie restricted humans
$425,958Jennifer Helene Stern · University Of Arizona · R21 · FY2025 · AG
Molecular Regulation of Apoprotein B Degradation
$425,945Edward A Fisher · New York University School Of Medicine · R01 · FY2009 · HL
Combining experiments of man and nature to target human insulin resistance
$425,859Amit Majithia · University Of California, San Diego · R01 · FY2023 · DK
Mechanistically based therapeutic strategies in murine primary biliary cholangitis
$425,665Merrill E Gershwin · University Of California At Davis · R01 · FY2020 · DK
Mammalian bile acid detection, processing, and impact on social behavior
$425,654Julian P Meeks · University Of Rochester · R01 · FY2022 · DC
Mammalian bile acid detection, processing, and impact on social behavior
$425,654Julian P Meeks · University Of Rochester · R01 · FY2023 · DC
Mammalian bile acid detection, processing, and impact on social behavior
$425,654Julian P Meeks · University Of Rochester · R01 · FY2020 · DC
Mammalian bile acid detection, processing, and impact on social behavior
$425,654Julian P Meeks · University Of Rochester · R01 · FY2021 · DC
Nuclear Receptor Networks in Mucosal Immune Regulation
$425,643Mark Scott Sundrud · Dartmouth-Hitchcock Clinic · U01 · FY2023 · AI
PROJECT 4: Targeting Methionine Adenosyltransferases in Liver Metastasis
$425,539Shelly Chi-Loo Lu · Cedars-Sinai Medical Center · P01 · FY2023 · CA
Reno-protective mechanisms of EETs in acute and chronic obstructive nephropathy
$425,469Babu J Padanilam · University Of Nebraska Medical Center · R01 · FY2019 · DK
Lipid glyceryl ester homeostasis in macrophages and perturbation by environmental
$425,457Matthew K Ross · Mississippi State University · R15 · FY2012 · ES
Evaluating the impact of genetic ancestry and HIV on cirrhosis progression and response to statin therapy among a diverse multi-ethnic cohort of patients with cirrhosis
$425,398David Seth Goldberg · University Of Miami School Of Medicine · U01 · FY2022 · DK
Substrate Cycling in Energy Metabolism
$425,328University Of Texas Medical Br Galveston · R01 · FY2005 · DK
Liver Cancer Therapy by MiR-22 and Its Inducers
$425,256Yu-Jui Yvonne Wan · University Of California At Davis · R01 · FY2023 · CA